Canterbury DHB
This is a complex area with the recent introduction of effective non-transplant treatments (e.g., Imatinib). See the CML section of the Red Book for a discussion of SCT Indications. For a further discussion of CML refractory to Imatinib, refer to Imatinib or Allograft? in the CML section.
Topic Code: 8152